News
Unlocking the potential of wearables for an ageing population

Away from the mainstream success of FitBit, Apple Watch and co., the market for wearables targeted at ageing health challenges is growing rapidly. Agetech World looks at some of the devices and trends on the rise in this field.
Fall detection devices
As we age, we suffer more balance issues and become weaker, leading to falls.
These falls can be particularly worrying if the person is living alone, which is why fall detection wearables, which can alert family, a neighbour or carer that its owner might have fallen, are an important innovation.
Such devices are generally worn around the wrist or neck, and feature a button the wearer can press if they need help. Once activated, the device will notify loved ones, healthcare workers or emergency services and provide a GPS location, automatically sending help.
However, there’s not always the need for a specialist device; many smartwatches, such as the Apple Watch 4 series, feature a fall monitor, which is automatically switched on if the wearer is over 65.
Wearable heart monitors
Heart health becomes increasingly important for seniors, as natural changes in body organs and their functionality affect the circulation and blood vessels.
As such, the elderly are more vulnerable to cardiovascular conditions such as heart attacks and heart failure than other people in the population.
Many smartwatches and fitness trackers now feature a heart-monitoring function, offering solutions such as accurate heart reporting and resting heart rate readings, along with reminders to move if the wearer has been sedentary for too long.
There is also the option of a wearable chest strap, with none of the added distractions of a smartwatch.
These can also be used to detect atrial fibrillation (an irregular heartbeat), or bradycardia and tachycardia; abnormally low or high heart rates respectively.
Blood pressure tech
High blood pressure, or hypertension, is another problem that becomes more common the older we get and can lead to complications such as stroke, heart disease, eye problems or kidney failure.
While some people have symptoms of hypertension, such headaches and vision changes, many don’t have any, which means diagnosis and treatment is often left too late.
This is why regular blood pressure monitoring is crucial, and the new generation of wearable tech could be the solution.
While the tech is still in its infancy, and there are currently questions over its accuracy, recent developments by Apple and Samsung mean it could soon become mainstream.
Wearables for dementia
Dementia is estimated to affect around seven per cent of over-65s and can be traumatic for both patients and loved ones.
As memory and cognitive function worsens, patients will often become forgetful and unaware of their surroundings, leading them to wander.
A new generation of wearables use GPS technology and other data to monitor patients, alerting carers to any changes in activity, such as being too close to an exit or having left their home.
Medication reminders
Another aspect of growing older is the amount of medications needed as part of daily life, many at different times of the day.
While many smartwatches have a reminder function, there are a few wearables on the market solely dedicated to medication.
One, the MedCenter Daily Travel Watch, is even combined with a small pill container, ideal for travelling or attending hospital appointments.
Independent living
As well as the above specific options, there are a number of wearables on the market that offer a more general range of support.
The Buddi range, for example, focuses is on enabling people to live independently in their own homes for longer, through innovations such as fall detection, connectivity solutions and a location finder, all in one neat wristband.
Smartwatches
Smartwatches are full of innovative technology that can be of real benefit to the older generation too.
From heart rate and blood oxygen monitors to GPS and activity trackers, smartwatches can keep track of many aspects of an elderly person’s health, allowing them more independence and giving them and their caregivers access to vital information at the touch of a button.
The other added benefit of an all-purpose smartwatch is the lack of stigma attached; while a fall-detection pendant can be seen to highlight the user’s age and frailty, the latest generation of wearable tech is suitable for all ages.
After all, any of the wearables mentioned above are only of use if they are actually worn, so removing any stigma is of utmost importance.
News
Gut-friendly foods may damage heart, charity warns
News
Diabetes patients face increased risk of undiagnosed heart failure

People with diabetes may have undiagnosed heart failure that could be detected by a simple screening blood test, research suggests.
The TARTAN-HF trial found that one in four patients with diabetes who had at least one other risk factor for heart failure had undiagnosed heart failure detected through screening with a blood test and ultrasound scanning of the heart.
Experts said the findings show the extent of unrecognised heart failure in people with diabetes, and how the condition can be detected using a widely available blood test called NT-proBNP, which measures how much strain the heart is under.
They suggest a heart failure screening programme for diabetics could improve diagnosis rates, lead to earlier treatment and potentially reduce the risk of hospitalisation and death.
The study, involving 700 patients, was led by the University of Glasgow in collaboration with AstraZeneca, Roche Diagnostics, Us2.ai, NHS Greater Glasgow and Clyde and NHS Lanarkshire.
Dr Kieran Docherty, clinical senior lecturer at the University of Glasgow’s School of Cardiovascular and Metabolic Health, said: “Our results from the landmark TARTAN-HF trial identified heart failure in a large proportion of people living with diabetes, emphasising the need for a heart failure screening strategy in this group of patients.
“We know that many of the symptoms and signs of heart failure are non-specific, and may go unrecognised as potentially being due to heart failure for a long time.
“The strategy used in our trial is simple and easy to implement in clinical practice, and will aid in the early identification of heart failure in people with diabetes, and facilitate the initiation of medications that we know improve outcomes in patients with heart failure.”
The study, which began more than three years ago, involved more than 700 people with diabetes from the two health board areas who had at least one other risk factor for heart failure.
They were randomly assigned either to receive heart failure screening or to continue with their usual care.
Researchers found screening uncovered a large number of previously unrecognised cases of heart failure. Around one in four, or 24.9 per cent, of those screened were found to have the condition within six months, compared with 1 per cent in the group continuing their usual care.
The study, involving patients with type 1 and type 2 diabetes, found almost all of the participants found to have heart failure had preserved ejection fraction, which can be difficult to detect without dedicated testing.
The findings of the TARTAN-HF trial were presented at the American College of Cardiology conference taking place from 28 to 30 March in New Orleans in the US.
Dr Edward Piper, medical director at AstraZeneca UK, said: “Delayed diagnosis and treatment of heart failure in people with type 2 diabetes contributes to poor long-term outcomes. TARTAN-HF demonstrates that targeted, risk-based screening can identify previously undiagnosed heart failure in approximately one in four high-risk patients with diabetes, enabling earlier intervention with guideline-directed therapy.”
Dr Christian Simon, head of global medical affairs at Roche Diagnostics, said: “We are proud to have supported the landmark TARTAN-HF trial. These findings demonstrate the transformative power of early, accessible diagnostics like the NT-proBNP blood test.
“By identifying unrecognised heart failure in people with diabetes, we enable clinicians to initiate appropriate treatments sooner, ultimately improving patient outcomes and lives.”
News
UK government announces £6.3m fund to boost men’s health

The UK has launched a £6.3m men’s health fund to back local projects aimed at helping men and boys live longer, healthier lives.
The Men’s Health Community Fund is a partnership between the Department of Health and Social Care, Movember and People’s Health Trust.
The government is contributing £3m, while the two charities are more than doubling that to take the total to £6.3m.
Grants will support community projects reaching underserved men and boys aged 16 and over, particularly in the most disadvantaged areas and at key points in their lives such as becoming a father, losing a job or retiring.
Projects could include support for new fathers, activities for men facing loneliness and social isolation, services to help young men engage with the health system, and support for men in work, out of work and moving into retirement.
The programme will bring together voluntary, community and social enterprise organisations to test new ways of reaching men who are least likely to use traditional health services.
An evaluation funded through the National Institute for Health and Care Research will assess what works and help inform future policy and delivery.
Health and social care secretary Wes Streeting said: “Too many men across the country are living shorter, less healthy lives, particularly those in our most disadvantaged communities.
“This new partnership will help men get the support they need in the places they feel most comfortable, their communities, among people they trust.
“By working with expert charities and local organisations, we can reach the men who are too often missed by traditional services and help them take better care of their mental and physical health.”
“It is a key step in delivering our first ever Men’s Health Strategy and driving forward our ambition to halve the gap in healthy life expectancy between the richest and poorest areas.”
The Men’s Health Strategy sets out plans to tackle the physical and mental health challenges men and boys face.
Men can be less likely to seek help and more likely to suffer in silence, while higher rates of smoking, drinking, gambling and drug use are damaging men’s health and affecting families, workplaces and communities.
The government is also investing £3.6m over the next three years in suicide prevention projects for middle-aged men in local communities across areas of England where men are most at risk, many of which are also among the most deprived. Suicide is one of the biggest killers of men under 50, and three-quarters of all suicides are men.
The projects will aim to break down barriers middle-aged men face in seeking support, including stigma around asking for help and a lack of awareness of what is available and how to access it.
They will be co-designed with experts and men with lived experience of mental health crises and suicidal thoughts.







